Where is operational tooling going?

A new radar imaging method could make ground deformation monitoring denser, cleaner, and more reliable across complex ...

Abstract: Despite strong performances on many generative tasks, diffusion and flow matching models require a large number of sampling steps to generate high-quality images. This has motivated the ...

Hello, and welcome to today's webinar, What's Next on the Workiva AI Roadmap For 2026. At the bottom of your screen are multiple application engagement tools that you can use. All the engagement tools ...

Lucid Motor said it expects to be cash flow positive late this decade. The company held its first investor day in nearly five years as a public company. The EV company is aiming to hit that target ...

Claude can now generate visuals when producing a response. (Anthropic) With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its ...

Anthropic, the maker of the AI chatbot Claude, says it has built an early warning system to track which U.S. jobs are most exposed to artificial intelligence — and its initial findings suggest many ...

All the Latest Game Footage and Images from Super Mario Maker: World Engine Super Mario Maker: World Engine is a fangame inspired by Super Mario Maker, including many new features and improvements ...

In a matter of months, Oracle has given investors epic highs and painful lows. Oracle Cloud Infrastructure (OCI) has competitive advantages over rival solutions. OCI's expansion is becoming ...

I recently saw a tweet showing how Google has acquired companies over the years and built products around them. Here is the link to the tweet if you want. Now, Google made another announcement: Google ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...